January 17, 2012

Preclinical vaccine shrinks tumors 80%


 Researchers at the Mayo Clinic and the University of Georgia have conducted preclinical trials of a vaccine that trains the body to recognize a protein called MUC1 that's present on 70% of cancers… The mice, developed by the Mayo Clinic's Sandra Gendler, have tumors that overexpress MUC1… "This is the first time that a vaccine has been developed that trains the immune system to distinguish and kill cancer cells based on their different sugar structures on proteins such as MUC1," Gendler explained in a statement. Additional Coverage: Atlanta Journal Constitution, Mother Nature Network

Fierce Vaccines,  by Maureen Martino, 12/2011

Tags: Cancer, Mayo Clinic Arizona

Please sign in or register to post a reply.
Contact Us · Privacy Policy